Literature DB >> 3487790

Experimental autoimmunity.

R B Nussenblatt, H C Gunn, B Ryffel, J F Borel.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3487790

Source DB:  PubMed          Journal:  Prog Allergy        ISSN: 0079-6034


× No keyword cloud information.
  7 in total

1.  Physiologic modeling of cyclosporin kinetics in rat and man.

Authors:  A Bernareggi; M Rowland
Journal:  J Pharmacokinet Biopharm       Date:  1991-02

Review 2.  Cyclosporin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in immunoregulatory disorders.

Authors:  Diana Faulds; Karen L Goa; Paul Benfield
Journal:  Drugs       Date:  1993-06       Impact factor: 9.546

3.  EAU in the guinea pig: inhibition of cell-mediated immunity and Ia antigen expression by cyclosporin A.

Authors:  J Liversidge; A W Thomson; H F Sewell; J V Forrester
Journal:  Clin Exp Immunol       Date:  1987-09       Impact factor: 4.330

4.  Response to autoimmune enteropathy to cyclosporin A therapy.

Authors:  I R Sanderson; A D Phillips; J Spencer; J A Walker-Smith
Journal:  Gut       Date:  1991-11       Impact factor: 23.059

5.  Repertoire analysis and new pathogenic epitopes of IRBP in C57BL/6 (H-2b) and B10.RIII (H-2r) mice.

Authors:  Lizette M Cortes; Mary J Mattapallil; Phyllis B Silver; Larry A Donoso; Gregory I Liou; Wei Zhu; Chi-Chao Chan; Rachel R Caspi
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-05       Impact factor: 4.799

6.  Human retinal pigment epithelial cells differentially express MHC class II (HLA, DP, DR and DQ) antigens in response to in vitro stimulation with lymphokine or purified IFN-gamma.

Authors:  J M Liversidge; H F Sewell; J V Forrester
Journal:  Clin Exp Immunol       Date:  1988-09       Impact factor: 4.330

7.  Heterotransplantation of human uveal melanoma.

Authors:  P E Liggett; G Lo; K J Pince; N A Rao; S G Pascal; J Kan-Mitchel
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1993       Impact factor: 3.117

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.